与瘤相关的高内皮静脉作为癌症免疫治疗中的治疗调节标
Jun-Ye Zhang1, Zhi-Yan Piao1, Guang-Liang Su1
1State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, Key Laboratory of Oral Biomedicine Ministry of Education, Hubei Key Laboratory of Stomatology, School & Hospital of Stomatology, Frontier Science Center for Immunology and Metabolism, Taikang Center for Life and Medical Sciences, Wuhan University, Wuhan 430079, China.
Biochimica et biophysica acta. Reviews on cancer
|November 30, 2025
概括
高内皮静脉 (HEV) 和三级淋巴体结构 (TLS) 对抗瘤免疫至关重要. 本综述探讨了它们的交互系统和提高癌症免疫疗法疗效的策略.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 血管生物学 血管生物学
背景情况:
- 免疫疗法在癌症治疗中表现有前途,但反应率有限.
- 高内皮静脉 (HEV) 和三级淋巴体结构 (TLS) 是抗瘤免疫的关键组成部分.
- 现有的研究往往孤立地研究HEV和TLS,忽视了它们相互关联的作用.
研究的目的:
- 系统地审查瘤相关的高内皮静脉管 (TA-HEVs) 和TLSs之间的相互依赖和相互作用.
- 突出诱导内HEV和TLS的药理策略,以改善免疫疗法.
- 讨论HEV/TLS研究和向治疗的未来方向.
主要方法:
- 系统性文献审查,重点关注TA-HEV和TLS的开发,组织和功能.
- 对目前针对HEV和TLS诱导的药理学策略的分析.
- 探索新兴的HEV检测方法和形成的分子机制.
主要成果:
- HEV和TLS形成了一个统一的,在时间空间上交互的系统,对有效的抗瘤免疫至关重要.
- 诱导内HEV和TLS可以显著提高癌症免疫治疗的疗效.
- 药理学策略存在,以调节HEV和TLS形成以获得治疗效益.
结论:
- 了解HEV和TLS的综合作用对于推进癌症免疫治疗至关重要.
- 准HEV/TLS系统为开发更有效的精密疗法提供了一个有希望的途径.
- 需要进一步研究HEV形成机制和检测方法,以优化治疗策略.
相关概念视频
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
The Tumor Microenvironment
7.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K
Regulation of Angiogenesis and Blood Supply
3.3K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.3K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Mechanism of Angiogenesis
6.6K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
6.6K
Cancer Vaccines
932
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
932


